Celgene Corp. (CELG)

Total Asset Turnover since 2005

Difficulty: Beginner

Celgene Corp., total asset turnover, long-term trends, calculation

	Total Asset Turnover	=	Net product sales¹	÷	Total assets¹
Dec 31, 2005	0.36	=	446	÷	1,247
Dec 31, 2006	0.30	=	812	÷	2,736
Dec 31, 2007	0.36	=	1,300	÷	3,611
Dec 31, 2008	0.48	=	2,138	÷	4,445
Dec 31, 2009	0.48	=	2,567	÷	5,389
Dec 31, 2010	0.34	=	3,508	÷	10,177
Dec 31, 2011	0.47	=	4,700	÷	10,006
Dec 31, 2012	0.46	=	5,386	÷	11,734
Dec 31, 2013	0.48	=	6,362	÷	13,378
Dec 31, 2014	0.44	=	7,564	÷	17,340
Dec 31, 2015	0.34	=	9,161	÷	27,053
Dec 31, 2016	0.40	=	11,185	÷	28,086
Dec 31, 2017	0.43	=	12,973	÷	30,141

¹ USD $ in millions

Source: Based on data from Celgene Corp. Annual Reports

Celgene Corp., total asset turnover, long-term trends, comparison to competitors

	Celgene Corp.	Abbott Laboratories	AbbVie Inc.	Allergan PLC	Amgen Inc.	Biogen Inc.	Bristol-Myers Squibb Co.	Eli Lilly & Co.	Gilead Sciences Inc.	Johnson & Johnson	Merck & Co. Inc.	Pfizer Inc.	Regeneron Pharmaceuticals Inc.
Dec 31, 2005	0.36	0.77	–	0.53	0.41	0.29	0.68	0.60	0.48	0.87	0.49	0.44	0.16
Dec 31, 2006	0.30	0.62	–	0.53	0.41	0.31	0.70	0.71	0.63	0.76	0.51	0.42	0.11
Dec 31, 2007	0.36	0.65	–	0.72	0.41	0.37	0.74	0.70	0.64	0.75	0.50	0.42	0.13
Dec 31, 2008	0.48	0.70	–	0.69	0.40	0.48	0.70	0.70	0.72	0.75	0.51	0.43	0.36
Dec 31, 2009	0.48	0.59	–	0.47	0.36	0.51	0.61	0.80	0.67	0.65	0.24	0.23	0.51
Dec 31, 2010	0.34	0.59	–	0.61	0.34	0.58	0.63	0.74	0.64	0.60	0.43	0.35	0.42
Dec 31, 2011	0.47	0.64	–	0.68	0.31	0.56	0.64	0.72	0.47	0.57	0.46	0.36	0.34
Dec 31, 2012	0.46	0.59	0.68	0.42	0.31	0.54	0.49	0.66	0.44	0.55	0.45	0.32	0.66
Dec 31, 2013	0.48	0.51	0.64	0.38	0.28	0.58	0.42	0.66	0.48	0.54	0.42	0.30	0.71
Dec 31, 2014	0.44	0.49	0.72	0.25	0.28	0.68	0.47	0.53	0.71	0.57	0.43	0.29	0.73
Dec 31, 2015	0.34	0.49	0.43	0.11	0.29	0.55	0.52	0.56	0.62	0.53	0.39	0.29	0.73
Dec 31, 2016	0.40	0.40	0.39	0.11	0.28	0.50	0.58	0.55	0.53	0.51	0.42	0.31	0.70
Dec 31, 2017	0.43	0.36	0.40	0.13	0.27	0.52	0.62	0.51	0.37	0.49	0.46	0.31	0.67

Source: Based on data from Celgene Corp. Annual Reports

Celgene Corp., total asset turnover, long-term trends, comparison to Pharmaceuticals & Biotechnology sector

	Celgene Corp.	Pharmaceuticals & Biotechnology
Dec 31, 2005	0.36	0.57
Dec 31, 2006	0.30	0.55
Dec 31, 2007	0.36	0.56
Dec 31, 2008	0.48	0.58
Dec 31, 2009	0.48	0.40
Dec 31, 2010	0.34	0.47
Dec 31, 2011	0.47	0.48
Dec 31, 2012	0.46	0.46
Dec 31, 2013	0.48	0.43
Dec 31, 2014	0.44	0.44
Dec 31, 2015	0.34	0.38
Dec 31, 2016	0.40	0.38
Dec 31, 2017	0.43	0.37

Source: Based on data from Celgene Corp. Annual Reports

Celgene Corp., total asset turnover, long-term trends, comparison to Health Care industry

Source: Based on data from Celgene Corp. Annual Reports